Navigation Links
Study of Infants in Neonatal ICU Shows Low BPA Exposures Are Well Within Safe Limits
Date:2/17/2013

WASHINGTON, Feb. 18, 2013 /PRNewswire-USNewswire/ -- A study published today in Pediatrics attempted to determine whether feeding sources (breast milk or formula) or needed medical devices were the sources of BPA exposure among premature infants under medical care in a hospital intensive care unit.  The study authors, Duty, et. al, tested urine samples from infants to determine exposure levels and noted whether the infants were exposed to "high-intensity" or "low-intensity" treatment with medical devices. The following statement on the topic can be attributed to Steven G. Hentges , Ph.D., of the Polycarbonate/BPA Global Group of the American Chemistry Council.

"Balancing the benefits and risks of any medical treatment is especially important when an infant's life is at stake and this study found that exposures to BPA from the use of life-saving medical equipment on premature infants in the NICU were low and well within safe limits established by regulators. The findings are consistent with an earlier study from some of the same researchers, which noted: 'More impor­tant, our findings suggest that even premature infants have some capacity to conjugate (process) BPA.'  Combined with more extensive studies, the available evidence indicates that even premature infants have the capability to quickly metabolize and eliminate BPA from the body, similar to adults.

"The BPA exposures for all of the infants in this study are short-term, limited to the time when life-saving medical treatment is necessary, and well below government-set safe intake limits for BPA, which are conservatively set. The authors acknowledge that exposures were 'below the U.S. Environmental Protection Agency reference dose (RfD) (dose below which no adverse health effects should result from a lifetime of exposure).'

"Overall, the results of this study are consistent with U.S. Food and Drug Administration policy to maximize the benefits of medical devices with minimal risk."

www.americanchemistry.com/newsroom

The American Chemistry Council (ACC) represents the leading companies engaged in the business of chemistry. ACC members apply the science of chemistry to make innovative products and services that make people's lives better, healthier and safer. ACC is committed to improved environmental, health and safety performance through Responsible Care®, common sense advocacy designed to address major public policy issues, and health and environmental research and product testing. The business of chemistry is a $760 billion enterprise and a key element of the nation's economy. It is the largest exporting sector in the U.S., accounting for 12 percent of U.S. exports. Chemistry companies are among the largest investors in research and development. Safety and security have always been primary concerns of ACC members, and they have intensified their efforts, working closely with government agencies to improve security and to defend against any threat to the nation's critical infrastructure.


'/>"/>
SOURCE American Chemistry Council
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
2. Study Showed Patients Treated With The miraDry© System Experienced 82 Percent Sweat Reduction On Average
3. Asubio Initiates Landmark Clinical Study in Spinal Cord Injury
4. New Veridex Alliance Drives Study Of Circulating Tumor Cells In Men With Metastatic Prostate Cancer
5. Shingles Vaccine is Safe, According to New Study
6. Structural Trends to Profoundly Change Life Sciences Industry, Genpact Study Shows
7. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
8. Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study
9. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
10. Accuray Launches First Study to Compare CyberKnife® SBRT to Surgery and IMRT for Treatment of Early-Stage Prostate Cancer
11. Interim results of VITOBA™ (VImpaT® added to One Baseline AED) Study Presented at the 64th Annual Meeting of the American Academy of Neurology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/11/2017)... May 11, 2017  Thornhill Research Inc. ( ... awarded an $8,049,024 USD five-year, firm-fixed-priced, indefinite-quantity/indefinite-delivery contract ... Canadian Commercial Corporation (CCC) ( Ottawa, Ontario, ... to administer general anesthesia to patients requiring emergency ... "The US Marine Corps have been a longtime ...
(Date:5/10/2017)... May 10, 2017 CSSi, the global leader ... clinical research industry, is proud to announce the launch ... new website features both enriched content and a customized ... enhances the company,s already well-established position as the top ... "After many months of hard work, we are ...
(Date:5/8/2017)... YORK , May 8, 2017 ... the transition from fee for service reimbursement. Black Book ... 2017. 1.       The Market for MIPS ... 77% of physician practices with 3 or more ... Technology Solutions by Q4. "Given the magnitude of the ...
Breaking Medicine Technology:
(Date:5/23/2017)... San Diego, CA (PRWEB) , ... May 23, 2017 , ... ... including bleeding gums and chronic bad breath, can now receive laser gum disease treatments ... Addleson, R. Douglas Campbell and David Landau are raising awareness of the importance of ...
(Date:5/22/2017)... ... May 22, 2017 , ... Patients who avoid necessary dental and endodontic treatments ... Mt. Kisco, NY from Advanced Endodontics of Westchester. This highly-trained team of endodontists offer ... or more sedation methods may be recommended based on the severity of the anxiety ...
(Date:5/22/2017)... Galena, Alaska (PRWEB) , ... May 22, 2017 , ... ... town near the Arctic Circle made big headlines when it was targeted to build ... Low-Cost Energy in Bush Alaska,” former city manager Marvin L. Yoder describes the journey ...
(Date:5/21/2017)... , ... May 19, 2017 , ... ... to announce the appointment of James (Jim) Vertino as Chief Information Officer (CIO). ... proven, transformational leader who drives innovation and business performance. He defines strategic roadmaps ...
(Date:5/21/2017)... Melbourne, FL (PRWEB) , ... May 21, 2017 , ... ... to announce the opening of its newest location at 109 Silver Palm Ave., Melbourne, ... Dr. Rodolfo Gari. , With the opening of the Melbourne practice, PPOA operates 23 ...
Breaking Medicine News(10 mins):